scorecardresearch
Add as a preferred source on Google
Friday, April 10, 2026
TopicCovid drug

Topic: Covid drug

Free Covid precaution doses for 18-59 age group from July 15 at govt centres

As part of Centre’s Azadi Ka Amrit Mahotsav, this initiative will continue for 75 days.

WHO recommends two new Covid drugs, in discussions to secure ‘equitable access’

Extent to which Baricitinib & Sotrovimab will save lives depends on how available, affordable they will be, says WHO. New guidelines advise against use of Remdesivir, Ivermectin.

WHO approves Glaxo and Eli Lilly drugs to treat Covid amid Omicron surge

Eli Lilly’s rheumatoid arthritis drug and GlaxoSmithKline's monoclonal antibody won the WHO nod.

Antiviral Molnupiravir not in govt Covid protocol, but ‘millions of doses’ distributed in a week

Pharma companies say doctors working in community settings have begun pre-ordering the drug, several manufacturers gearing up to meet demand.

Scientists launch hunt to find naturally Covid-resistant people, 1,000 volunteers to be enrolled

The study looks for people genetically resistant to SARS-CoV-2 virus — if such natural immunity exists. Candidates are one of a couple, where only one partner fell sick, despite close contact.

No benefits of Doxycycline found in UK Covid patients, write Oxford researchers in Lancet study

According to researchers, the drug that has been commonly used to treat Covid respiratory symptoms does not reduce recovery time, hospital admissions, or deaths related to Covid.

Has Covid exposed limitations of ‘secretive’ ICMR? Some experts think so

The ICMR has increasingly drawn criticism from India's doctors and scientists, who have questioned its drug recommendations & lack of transparency on data related to variants.

Pharma firms and diagnostics developers need to unite. They are catalysts for saving lives

Studies of drugs like remdesivir and hydroxychloroquine were underpowered and small, and the results were conflicting and, in many cases, inconclusive.

Molnupiravir helps in faster recovery of mild Covid patients, says Hetero after phase 3 trials

Hyderabad-based pharma company, Hetero, announced promising interim results of phase 3 trials and has approached DCGI for emergency use authorisation for the drug in India.

Why Covid drug Ivermectin remains popular despite warnings & lack of evidence on efficacy

University of Oxford has launched a large study to investigate the use of Ivermectin for Covid-19 treatment, amid guidelines across the world, warning against the use of the drug. 

On Camera

What can be expected from the ongoing talks in Islamabad? Odds of resolution remain slim

The initial ceasefire functioned less as a resolution and more as a pause—an opportunity for both sides to recalibrate, while claiming victory.

India bond yields rise as RBI moves to drain liquidity, lift overnight rates

New Delhi: India’s sovereign bond yields rose after the central bank announced its first step this year to drain cash from the banking system,...

Army promotes Col Purohit, acquitted in 2008 Malegaon blast case, to Brigadier; to not retire yet

This means he will serve Indian Army for a minimum of another 2 years as Brigadier, unless he picks up the next rank of Major General.

China insulated itself against energy shocks. India is ‘all talk, no walk’

China patiently invested capital, skill and technology in coal gasification. Unlike it, we won’t move from words to action. As crude prices decline, we lose interest.